© 2020 MJH Life Sciences and OncLive. All rights reserved.
January 16, 2020
Maria Chaudhry, MBBS, a hematologist at The Ohio State University Comprehensive Cancer Center—James, discusses novel treatment regimens in relapsed/refractory multiple myeloma.
January 09, 2020
Maria Chaudhry, MBBS, discusses unmet needs in relapsed/refractory multiple myeloma.
January 07, 2020
Maria Chaudhry, MBBS, discusses the use of daratumumab (Darzalex), lenalidomide (Revlimid), and dexamethasone in transplant-ineligible patients with multiple myeloma.